Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Nucleic Acids and Circulating Rare Cells: Liquid Biopsy for Early Cancer Detection

Brian Dougherty's Biography



Brian Dougherty, Director, Translational Genomics, AstraZeneca Oncology

Brian’s responsibilities at AstraZeneca include coordinating the delivery of genetic /genomic technologies, including Next-Gen sequencing, for Oncology translational /clinical teams with the goal of developing DNA-based biomarkers, patient selection strategies, and identifying new genetics-based cancer targets. At previous companies (TIGR, Bristol-Myers Squibb, Pfizer, and Amgen), Brian has managed sequencing and functional genomics labs, applying technologies to enable the discovery and development of medicines for cancer, infectious diseases, and Alzheimer’s.

Brian Dougherty Image

Sequencing and Analysis of Patient Liquid Biopsies

Thursday, 29 March 2018 at 11:30

Add to Calendar ▼2018-03-29 12:00:002018-03-29 13:00:00Europe/LondonSequencing and Analysis of Patient Liquid BiopsiesSELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2018-03-28 00:00:002018-03-29 00:00:00Europe/LondonCirculating Nucleic Acids and Circulating Rare Cells: Liquid Biopsy for Early Cancer Detection SELECTBIOenquiries@selectbiosciences.com